【摘要】 目的 探讨达芬奇Xi系统单一体位经腹腔肾输尿管全长切除术在治疗上尿路尿路上皮癌中的可行性及安全性。方法 回顾性分析青岛市市立医院东院区2019年11月至2020年11月收治的11例患者资料。其中男7例，女4例，年龄50～77岁。肾盂癌5例，输尿管癌5例，肾盂癌合并输尿管癌1例。肿瘤位于左侧6例，右侧5例。应用达芬奇Xi系统，术中不变换体位。结果11台手术均顺利应用达芬奇Xi系统完成，无中转开放或腹腔镜手术。术中出血量30～300 ml。手术时间110～210 min。术后住院时间8～13 d。术后无ClavienⅡ级以上并发症。术后随访时间0～12个月，失访2例，无死亡及肿瘤复发病例。结论 单一体位经腹腔肾输尿管切除术能较好地发挥达芬奇Xi系统的优势，手术时间明显较短，术后恢复快，肿瘤切除效果较好，短期随访结果满意。更多还原

【Abstract】 Objective To investigate and evaluate the safety and effect of single-position transperitoneal robotic-assisted nephroureterectomy with the da Vinci Xi robotic system. Methods A total of 11 patients’ clinical data from November 2019 to November 2020 in our hospital was retrospectively analyzed, including 7 males and 4 females. The age was 50-77 years. Of the 11 localized upper tract urothelial carcinoma(UTUC) patients including, 5 renal pelvic tumors, 5 ureter tumors, 1 ureter tumors combined with renal pelvic tumor. There were 6 cases on the left side, and 5 cases on the right.Single-position transperitoneal robot-assisted nephroureterectomy with the da Vinci Xi robotic system was performed on all the patients. Results All procedures were successful.The median operation time was 155(110-210) min, and the median estimated blood loss of 92(30-300) ml. The median length of stay was 10.5(8-13) d. None Clavien grade Ⅱ-Ⅴ complications was occurred after surgery. The median length of follow-up was 4.3(0-12) months. None recurrence and died case until November 2020. Conclusions The single-position transperitoneal robotic-assisted nephroureterectomy with the da Vinci Xi robotic system is a safe and efficacious procedure. The postoperative recover time is reduced. Short-term follow-up results prompt good tumor control effect.更多还原